Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Update

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 415,800 shares, a drop of 48.2% from the February 28th total of 803,100 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 1,625,800 shares, the short-interest ratio is presently 0.3 days.

Bayer Aktiengesellschaft Stock Up 0.1 %

Shares of Bayer Aktiengesellschaft stock opened at $6.15 on Friday. Bayer Aktiengesellschaft has a 52-week low of $4.79 and a 52-week high of $8.58. The firm’s 50 day moving average price is $5.94 and its 200-day moving average price is $6.12. The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19. The company has a market cap of $24.15 billion, a P/E ratio of -23.63 and a beta of 1.02.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.